1. Home
  2. TNXP vs GIGM Comparison

TNXP vs GIGM Comparison

Compare TNXP & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • GIGM
  • Stock Information
  • Founded
  • TNXP 2007
  • GIGM 1998
  • Country
  • TNXP United States
  • GIGM Taiwan
  • Employees
  • TNXP N/A
  • GIGM N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • GIGM Computer Software: Programming Data Processing
  • Sector
  • TNXP Health Care
  • GIGM Technology
  • Exchange
  • TNXP Nasdaq
  • GIGM Nasdaq
  • Market Cap
  • TNXP 335.6M
  • GIGM 17.0M
  • IPO Year
  • TNXP N/A
  • GIGM 2000
  • Fundamental
  • Price
  • TNXP $27.71
  • GIGM $1.81
  • Analyst Decision
  • TNXP Buy
  • GIGM
  • Analyst Count
  • TNXP 1
  • GIGM 0
  • Target Price
  • TNXP $70.00
  • GIGM N/A
  • AVG Volume (30 Days)
  • TNXP 1.2M
  • GIGM 22.4K
  • Earning Date
  • TNXP 11-11-2025
  • GIGM 10-29-2025
  • Dividend Yield
  • TNXP N/A
  • GIGM N/A
  • EPS Growth
  • TNXP N/A
  • GIGM N/A
  • EPS
  • TNXP N/A
  • GIGM N/A
  • Revenue
  • TNXP $9,831,000.00
  • GIGM $3,250,000.00
  • Revenue This Year
  • TNXP $14.79
  • GIGM N/A
  • Revenue Next Year
  • TNXP $933.49
  • GIGM N/A
  • P/E Ratio
  • TNXP N/A
  • GIGM N/A
  • Revenue Growth
  • TNXP N/A
  • GIGM N/A
  • 52 Week Low
  • TNXP $6.76
  • GIGM $1.30
  • 52 Week High
  • TNXP $130.00
  • GIGM $1.89
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 39.85
  • GIGM 66.43
  • Support Level
  • TNXP $26.37
  • GIGM $1.61
  • Resistance Level
  • TNXP $31.55
  • GIGM $1.89
  • Average True Range (ATR)
  • TNXP 2.28
  • GIGM 0.09
  • MACD
  • TNXP 0.25
  • GIGM 0.02
  • Stochastic Oscillator
  • TNXP 38.91
  • GIGM 80.05

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About GIGM GigaMedia Limited

GigaMedia Ltd is a diversified provider of digital entertainment services. Its only segment and principal business is digital entertainment service business, which operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. It operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown.

Share on Social Networks: